English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Coronavirus disease 2019 (COVI 19) was first discovered in China when a pneumonia of unknown origin broke out in Wuhan, Hubei Province, China, affecting a cluster of people linked to a large seafood and live animal market in the area [1]. A novel coronavirus (n-CoV), currently known as SARS-CoV-2, was identified in the respiratory samples of the pneumonia patients [2]. The infection has since spread around the world, and has been classified as a pandemic by the WHO [3]. It has affected over 10.7 million people and claimed as much as 517,877 lives as of 26 May 2020 [4]. Journal of Clinical & Biomedical Research

Lack of Robust Laboratory Testing Infrastructure in Nigeria: A Promoter of Community Transmission Outcome of COVID 19 Virus Indicator